Spinal Muscular Atrophy and Common Therapeutic Advances-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Spinal Muscular Atrophy and Common Therapeutic Advances

Published:2019-05-04 Issue:3 Volume:38 Page:226-238
ISSN:1551-3815
Container-title:Fetal and Pediatric Pathology
language:en
Short-container-title:Fetal and Pediatric Pathology

Author:

Bozorg Qomi Saeed¹²^ORCID,Asghari Amir³,Salmaninejad Arash⁴^ORCID,Mojarrad Majid¹²^ORCID

Affiliation:

1. Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;

2. Medical Genetics Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;

3. Department of Medical Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;

4. Drug Applied Research Center, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

Publisher

Informa UK Limited

Subject

General Medicine,Pathology and Forensic Medicine,Pediatrics, Perinatology, and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/15513815.2018.1520374

Reference96 articles.

1. Spinal muscular atrophy

2. Spinal muscular atrophy

3. Newborn and carrier screening for spinal muscular atrophy

4. Genetic risk assessment in carrier testing for spinal muscular atrophy

5. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q1 1.2–13.3

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Mechanisms of Medicinal Plant Securinega suffruticosa-derived Compound Securinine against Spinal Muscular Atrophy based on Network Pharmacology and Experimental Verification;Current Pharmaceutical Design;2024-04

2. Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression;2022-03-21

3. Systematic review and meta-analysis determining the benefits of in vivo genetic therapy in spinal muscular atrophy rodent models;Gene Therapy;2021-10-06

4. Onasemnogene Abeparvovec-xioi: World’s most expensive and approved therapy for spinal muscular atrophy;NeuroPharmac Journal;2021-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3